1.
Diagnosis, management and prevention of drug-induced liver injury
by Verma, S
Gut, 2009-11, Vol.58 (11), p.1555-1564

2.
Drug hypersensitivity: Pharmacogenetics and clinical syndromes
by Phillips, Elizabeth J., MD
Journal of allergy and clinical immunology, 2011, Vol.127 (3), p.S60-S66

3.
Using Genome-Wide Association Studies to Identify Genes Important in Serious. Adverse Drug Reactions
by DALY, Ann K
Annual review of pharmacology and toxicology, 2012, Vol.52 (1), p.21-35

4.
Adverse effects of antiretroviral therapy
by Carr, Andrew
The Lancet (British edition), 2000, Vol.356 (9239), p.1423-1430

5.
Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues
by Blanche, Stéphane
The Lancet (British edition), 1999, Vol.354 (9184), p.1084-1089

6.
Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection
by Lafeuillade, Alain
The Lancet (British edition), 2001-01-27, Vol.357 (9252), p.280-281

7.
Frequency of stavudine substitution due to toxicity in children receiving antiretroviral treatment in sub-Saharan Africa
by PALMER, Megan
AIDS (London), 2013, Vol.27 (5), p.781-785

8.
Oxygen radical-mediated pulmonary toxicity induced by some cationic liposomes
by DOKKA, S
Pharmaceutical research, 2000, Vol.17 (5), p.521-525

9.
Reversal of quetiapine-induced altered mental status with physostigmine: a case series
by Cole, Jon B., MD
The American journal of emergency medicine, 2012, Vol.30 (6), p.950-953

10.
Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs
by Smecuol, E
Gut, 2001-11, Vol.49 (5), p.650-655

11.
A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children
by LATTA, Kay
Pediatric nephrology (Berlin, West), 2001, Vol.16 (3), p.271-282

12.
Diuretic Complications
by Greenberg, Arthur
The American journal of the medical sciences, 2000-01, Vol.319 (1), p.10-24

13.
Bcl-2 Gene Therapy Prevents Aminoglycoside-Induced Degeneration of Auditory and Vestibular Hair Cells
by Pfannenstiel, Susanna C
Audiology & neurotology, 2009-05, Vol.14 (4), p.254-266

14.
Infection-Mediated Vasoactive Peptides Modulate Cochlear Uptake of Fluorescent Gentamicin
by Koo, Ja-Won
Audiology & neurotology, 2011-09, Vol.16 (6), p.347-358

15.
Clinical manifestations and management of antiretroviral nucleoside analog-related mitochondrial toxicity
by Moyle, Graeme
Clinical therapeutics, 2000-08, Vol.22 (8), p.911-936

16.

17.
Astragalosides Reduce Cisplatin Ototoxicity in Guinea Pigs
by Xiong, Min
O.R.L. Journal for oto-rhino-laryngology and its related specialties, 2011-06, Vol.73 (3), p.131-136

18.
Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")
by Henry, J.A
The Lancet (British edition), 1992-08-15, Vol.340 (8816), p.384-387

19.
Determinants of recurrent toxicity-driven switches of highly active antiretroviral therapy. The ATHENA Cohort
by Dieleman, Jeanne P
AIDS (London), 2002, Vol.16 (5), p.737-745

20.
Direct analysis of mitochondrial toxicity of antiretroviral drugs
by FOLI, Andrea
AIDS (London), 2001, Vol.15 (13), p.1687-1694
